PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 27677978

  • 1. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [Abstract] [Full Text] [Related]

  • 3. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [Abstract] [Full Text] [Related]

  • 4. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
    Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
    Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
    [Abstract] [Full Text] [Related]

  • 5. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
    Sheikh S, Mishra K, Kumar M.
    Pediatr Nephrol; 2021 Oct 08; 36(10):3143-3150. PubMed ID: 33861375
    [Abstract] [Full Text] [Related]

  • 6. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct 08; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 7. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
    Pediatr Nephrol; 2019 May 10; 34(5):829-835. PubMed ID: 30194663
    [Abstract] [Full Text] [Related]

  • 9. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
    Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
    BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
    [Abstract] [Full Text] [Related]

  • 10. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
    Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
    Am J Kidney Dis; 2003 Jun 23; 41(6):1155-62. PubMed ID: 12776266
    [Abstract] [Full Text] [Related]

  • 11. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
    Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
    [Abstract] [Full Text] [Related]

  • 12. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS, Shien CY, Chi CS.
    Nephron Clin Pract; 2004 Apr 27; 97(4):c137-41. PubMed ID: 15331936
    [Abstract] [Full Text] [Related]

  • 13. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
    Pediatr Nephrol; 2017 Aug 27; 32(8):1377-1382. PubMed ID: 28341877
    [Abstract] [Full Text] [Related]

  • 14. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
    Esezobor CI, Ladapo TA, Lesi FE.
    Niger J Clin Pract; 2016 Aug 27; 19(2):254-8. PubMed ID: 26856291
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R, Kaltenis P.
    Medicina (Kaunas); 2005 Aug 27; 41 Suppl 1():26-30. PubMed ID: 15901972
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
    Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
    Clin Exp Nephrol; 2020 Jul 27; 24(7):622-629. PubMed ID: 32201918
    [Abstract] [Full Text] [Related]

  • 17. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
    Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
    J Trop Pediatr; 2013 Oct 27; 59(5):343-9. PubMed ID: 23619602
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
    Christian MT, Webb NJA, Mehta S, Woolley RL, Afentou N, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Prajapati H, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    JAMA Pediatr; 2022 Mar 01; 176(3):236-243. PubMed ID: 34928294
    [Abstract] [Full Text] [Related]

  • 19. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
    Mishra OP, Thakur N, Mishra RN, Prasad R.
    J Nephrol; 2012 Mar 01; 25(3):394-400. PubMed ID: 21928226
    [Abstract] [Full Text] [Related]

  • 20. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.
    Srivastava RN, Vasudev AS, Bagga A, Sunderam KR.
    Pediatr Nephrol; 1992 May 01; 6(3):247-50. PubMed ID: 1616833
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.